Analyst Ratings for Pacific Biosciences of California (pacb)

pacb Rating Summary

pacb Price Target Summary

* Over Last 12-Mos
  |   Expand Research on pacb
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $3.10 (-29.4%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
8/2/2013 Piper Jaffray Upgrade Neutral
(Underweight)
3.10
(2.00)
2.67 4.39 64.42% Details
7/30/2012 Morgan Stanley Downgrade Underweight
(Equalweight)
N/A
(N/A)
2.00 4.39 119.5% Details
Like PACB Ratings? Also take a look at RHHBY

PACB Ratings News